Switch View
© BusinessWire
08.11.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 CORALreef Lipids trial demonstrating that treatment with enlicitide decanoate, an investigational, once-daily oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, resulted in a statist...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
News Preview
Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of life Oral presentation highlights sotagliflozin's unique benefits to HFpEF patients in significantly improving cardiac and physical performance, and quality of life...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Important Notice to Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office Is Investigating Claims on Your Behalf
News Preview
Philadelphia, Pennsylvania--(Newsfile Corp. - November 8, 2025) - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. (NYSE: INSP) shareholders. The investigation concerns whether certain officers of Inspire Medical have breached their fiduciary duties owed to the company.Current Inspire Medical shareholders who hav...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
08.11.2025
ISIN: US61225M1027
Monte Rosa Therapeutics Inc
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases
News Preview
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
08.11.2025
ISIN: US87990A1060
Tenaya Therapeutics Inc
TNYA
LISTED
NASDAQ
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
News Preview
MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular Research...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US0080642061
Jade Biosciences Inc
JBIO
LISTED
NASDAQ
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
News Preview
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today presented two posters for JADE101, its investigational anti-A PRoliferation-Inducing...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
News Preview
Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
News Preview
- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated:...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG). The studies met the primary endpoint, with olezarsen achieving a highly statistically significant placebo-adjusted mean reduction in fasting triglyceride (TG) le...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: CH0334081137
CRISPR Therapeutics AG
CRSP
LISTED
NASDAQ
CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering
News Preview
-Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025-...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - JSPR
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
News Preview
Organon (NYSE: OGN), a global independent healthcare company with a focus on women’s health, will present results from a sub-analysis of pooled data from the Phase 3 ADORING 1 and ADORING 2 pivotal trials evaluating VTAMA cream versus vehicle at the 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in Orla...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
08.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX DEADLINE: MoonLake Immunotherapeutics Investors with Losses are Notified to Contact BFA Law before December 15 Securities Class Action Deadline
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are e...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DXCM DEADLINE: DexCom, Inc. Investors with Losses are Notified to Contact BFA Law before December 26 Securities Class Action Deadline
News Preview
New York, New York--(Newsfile Corp. - November 8, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.11.2025
ISIN: US51654W1018
Lantern Pharma Inc.
LTRN
LISTED
NASDAQ
New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
News Preview
NEW YORK CITY, NEW YORK / ACCESS Newswire / November 8, 2025 / New to The Street announces the broadcast of Show Number 698, airing on Bloomberg Television this Saturday, November 8, 2025, at 6:30 PM EST, as sponsored programming.This week's show features exclusive interviews and insights from leading companies and financial professionals:Lantern P...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk will not increase its proposal to acquire Metsera, Inc.
News Preview
Novo Nordisk today confirms that it does not intend to make an increased offer to acquire Metsera....
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SVRA
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the "Class Period"), of the important November 7, 2025 lead plaintiff deadline.SO WHAT: If you purchased S...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LANTHEUS DEADLINE: ROSEN, TOP RANKED INVESTOR RIGHTS COUNSEL, Encourages Lantheus Holdings, Inc. Investors to Secure Counsel Before Important November 10 Deadline in Securities Class Action - LNTH
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), of the important November 10, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOH
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline.SO WHAT: If you pur...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ROSEN, A LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline.SO WHAT: I...
Themefolio
Profiler
Peergroup
© Newsfile
08.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Rosen Law Firm Urges Inspire Medical Systems, Inc. (NYSE: INSP) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”). Inspire Medical is a medical technology company.
For more information, submit a f...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US34965K1079
Fortrea Holdings Inc
FTRE
LISTED
NASDAQ
Fortrea Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Fortrea Holdings, Inc. (NasdaqGS: FTRE).
In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. In connection with...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Class Action Reminder: AVTR Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Avantor, Inc. Class Action Lawsuit
News Preview
SAN DIEGO, Nov. 7, 2025 /PRNewswire/ --
Company: Avantor, Inc. (NYSE: AVTR) provides scientific products and services for customers in biotech...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Stockholder Alert: Robbins LLP Informs Investors of the Inspire Medical Systems, Inc. Class Action Lawsuit
News Preview
SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025. Inspire is a medical technology company....
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s B...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
News Preview
Vera Therapeutics Submits BLA to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgAN...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US6031701013
Mineralys Therapeutics Inc
MLYS
LISTED
NASDAQ
Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025
News Preview
– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week –...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on November 5, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 11,250 shares of Puma common stock to two new non-executive employees.
The awards were granted under Puma’s 2017 Em...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Deadline Soon: Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusi...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
News Preview
PARSIPPANY, N.J., and TEL AVIV, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of new data from the ongoing, real-world IMPACT-TD Registry. The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US29350E2037
Lunai Bioworks Inc.
LNAI
LISTED
NASDAQ
Lunai Bioworks schafft es, sowohl primäre als auch metastasierte Bauchspeicheldrüsentumoren in präklinischen humanisierten Modellen komplett zurückzubilden, was einen Durchbruch in der allogenen Krebsimmuntherapie bedeutet
News Preview
Lunai Bioworks gibt die Veröffentlichung der allogenen dendritischen Zelltherapieplattform der zweiten Generation in der Fachzeitschrift „Vaccines" bekannt.
LOS ANGELES, 7. November 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), ein KI-gestütztes Unternehmen für Arzneimittelforschung und Bioa...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Deadline Approaching: Avantor, Inc. (AVTR) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR W...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: CA58504D1006
Medipharm Labs Corp
LABS
LISTED
TSX
/U P D A T E -- MediPharm Labs Corp./
News Preview
In the news release, MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees, issued 15-May-2025 by MediPharm Labs Corp. over PR Newswire, please be advised that updates have been made throughout the release and will replace the prior version in full:
MediPharm Labs Raises Concerns About Poorly Qua...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: CA58504D1006
Medipharm Labs Corp
LABS
LISTED
TSX
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
News Preview
TORONTO, May 13, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials") for its upcoming Annual and Spe...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US3596641098
Fulgent Genetics Inc
FLGT
LISTED
NASDAQ
Fulgent to Participate in Upcoming Conferences
News Preview
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that members of its management team are scheduled to present at the following upcoming investor conferences:
UBS Global Healthcare Conference...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants.
On November 4, 2025, as an inducement materi...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Shareholders that lost money on Avantor, Inc. (AVTR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Avantor, Inc. ("Avantor, Inc." or the "Company") (NYSE: AVTR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Investors in Baxter International, Inc. Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - BAX
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom, Inc." or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Shareholders that lost money on Lantheus Holdings, Inc.(LNTH) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Levi & Korsinsky Notifies Shareholders of aTyr Pharma, Inc. (ATYR) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Contact Levi & Korsinsky by November 17, 2025 Deadline to Join Class Action Against Cytokinetics, Incorporated(CYTK)
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Savara Inc.(SVRA) Shareholders
News Preview
NEW YORK, Nov. 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
News Preview
Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade in advanced melanoma following definitive anti-PD-1 failure Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade in advanced melanoma following definitive anti-PD-1 fa...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US68622P1093
Oric Pharmaceuticals Inc
ORIC
LISTED
NASDAQ
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on November 3, 2025 (the “Grant Date”), ORIC granted a total of 18,400 non-qualified stoc...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US3596161097
Fulcrum Therapeutics Inc
FULC
LISTED
NASDAQ
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to two new employees. Fulcrum...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US0396971071
Ardelyx Inc
ARDX
LISTED
NASDAQ
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
News Preview
WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the company presented data, including results from the first real-world study...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: IL0011681371
Nano-X Imaging Ltd
NNOX
LISTED
NASDAQ
Nanox to Report Third Quarter 2025 Financial Results on November 20, 2025
News Preview
Nanox to Report Third Quarter 2025 Results on November 20, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BRISBANE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on November 4, 2025, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 79,050 shares of Class A common stock and restricted stock u...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: US00773J2024
Spyre Therapeutics Inc
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Grants of Inducement Awards
News Preview
WALTHAM, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced that Spyre’s indepe...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
ISIN: NL00150012L7
NewAmsterdam Pharma Company N.V.
NAMS
LISTED
NASDAQ
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
NAARDEN, The Netherlands and MIAMI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Com...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
ROSEN, LEADING INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
News Preview
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the inves...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Carolina Complete Health and Centene Foundation Make $200,000 Investment to Help Tackle Food Insecurity in North Carolina
News Preview
Investment strengthens community food resources for families struggling to access healthy meals
CHARLOTTE, N.C., Nov. 7, 2025 /PRNewswire/ -- Carolina Complete Health and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announc...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR Deadline: Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors there is a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR), between November 30, 2023 and July 3, 2025. Jasper is a clinical-stage biotechnology company.
For more information, submit a form, email attorney Phillip Kim, or gi...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
